Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats
Parathyroid hormone (PTH) is an effective bone anabolic agent, but it must be administered parenterally. An orally active anabolic agent would provide a valuable alternative for treating osteoporosis. NPS 2143 is a novel, selective antagonist (a “calcilytic”) of the parathyroid cell Ca(2+) receptor....
Сохранить в:
| Опубликовано в:: | J Clin Invest |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
2000
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC300853/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10841518/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI9038 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
